SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 15.13
-1.50 (-9.02%)
At close: Dec 5, 2025
SkinBioTherapeutics Revenue
In the fiscal year ending June 30, 2025, SkinBioTherapeutics had annual revenue of 4.64M GBP with 283.74% growth. SkinBioTherapeutics had revenue of 1.58M in the half year ending December 31, 2024, with 1,947.84% growth.
Revenue
4.64M
Revenue Growth
+283.74%
P/S Ratio
8.44
Revenue / Employee
309.21K
Employees
15
Market Cap
39.14M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Convatec Group | 1.72B |
| Hikma Pharmaceuticals | 2.35B |
| HUTCHMED (China) | 439.54M |
| Genus | 672.80M |